Latest News - Hologic

Top Corporates Hub

Hologic

HOLX | NASDAQ | United States
989
Rank
$17.15B
Market Cap
$4.03B
+$ 0.07B
+1.77%
Revenue
$1.04B
+$ 0.31B
+42.47%
Earnings
7.1K
Employees
Halliburton's profit plummets, Hologic to go private in $18.3B deal

21.10.2025 14:45

Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including Galaxy Digital (GLXY.TO, GLXY) topping third quarter earnings estimates, Halliburton (HAL) seeing a massive drop in its net income, and Blackstone (BX) and TPG Inc. (TPG) agreeing to take Hologic (HOLX) private in a deal worth $18.3 billion. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.

Read More

Blackstone, TPG plan to take Hologic private in a deal worth more than $13 billion

21.10.2025 14:38

Private equity firms Blackstone and TPG will spend more than $13 billion to buy women’s health specialist Hologic. The companies said Tuesday they will pay up to $79 for each Hologic share in a deal that takes the company private. Shares of Hologic rose after markets opened Tuesday.

Read More

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

21.10.2025 13:18

Under the terms of the deal, Blackstone and TPG agreed to acquire all outstanding shares of the women’s-health company for $76 apiece in cash.

Read More

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

21.10.2025 12:41

MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas, October 21, 2025--Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

Read More

Hologic to go private for up to $18.3B

21.10.2025 10:54

Funds managed by Blackstone and TPG plan to acquire the medtech firm for up to $79 per share.

Read More

3 Cash-Producing Stocks with Open Questions

21.10.2025 04:35

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Read More

What to Expect From Hologic’s Next Quarterly Earnings Report

16.10.2025 10:10

Hologic is set to release its fourth-quarter earnings next month, and analysts are forecasting a solid high-single-digit increase in profits.

Read More

Hologic Expands Panther Fusion's Menu With Diagnostic Innovation

08.10.2025 12:20

HOLX expands its Panther Fusion platform with new GI bacterial assays, securing FDA and EU approvals to boost Diagnostics growth.

Read More

3 Reasons HOLX is Risky and 1 Stock to Buy Instead

08.10.2025 04:02

While the S&P 500 is up 34.7% since April 2025, Hologic (currently trading at $67.73 per share) has lagged behind, posting a return of 15.9%. This might have investors contemplating their next move.

Read More

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

02.10.2025 12:05

MARLBOROUGH, Mass., October 02, 2025--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Panther Fusion® Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. The company also announced that the assays obtained CE marking in the European Union in accordance with In Vitro Diagnostic Regulation (IVDR). These highly sensitive molecular tests are designed to rapidly detect the most common bacterial pathogens res

Read More

Volition Signs Co-Marketing and Services Agreement with Hologic

29.09.2025 13:30

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with Hologic Diagenode ("Hologic") for the co-marketing of Volition's Nu.Q® Discover service.

Read More

Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

29.09.2025 13:30

Minicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation of the Hologic Fluoroscan® Insight™ FD Mini C-Arm for resale in the United States. As Hologic transitions away from commercial activities related to the Fluoroscan Insight product line, Minicarm.com will continue to offer sales support for the remaining inventory, ensuring continuity and specialized service for U.S. customers.

Read More

Medical Devices & Supplies - Imaging, Diagnostics Stocks Q2 Highlights: Hologic (NASDAQ:HOLX)

29.09.2025 03:31

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics stocks, including Hologic (NASDAQ:HOLX) and its peers.

Read More

New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at EUSOBI

26.09.2025 12:00

MARLBOROUGH, Mass., September 26, 2025--New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at EUSOBI

Read More

HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?

24.09.2025 13:43

Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.

Read More

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

19.09.2025 14:00

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read More

Hologic (NASDAQ:HOLX) Hasn't Managed To Accelerate Its Returns

28.08.2025 17:23

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...

Read More

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

26.08.2025 13:00

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Read More

Bruker: Former Academia Customer Strength, Now Incredible Weakness

15.08.2025 03:31

Bruker faces challenges amid NIH funding cuts and academic reliance. Short-term risks are high, but investors may benefit from a recovery. See more on BRKR.

Read More

What Are Wall Street Analysts' Target Price for Hologic Stock?

14.08.2025 06:41

Although Hologic has underperformed the broader market over the past year, it has observed significant gains in recent months, and analysts are turning more optimistic on the stock’s prospects.

Read More